2025 fourth_quarter Filing

General issues related to over-the-counter (OTC) pharmaceutical supply chain.

Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.